Flat.Bio

Dexcom launches over-the-counter, prescription-free, continuous glucose monitor named Stelo. Recently Abbott also recevied FDA clearance of two similar devices

27 Aug 2024 • 6:26 PM EDT,

PermaLink

Jessica Rendall

CNET

Eli Lilly launches a new form of weight loss drug Zepbound for as low as $399 a month

27 Aug 2024 • 5:23 PM EDT,

PermaLink

Annika Kim Constantino

CNBC

Nature Biotechnology article: Biotech financing: darkest before the dawn

08 Aug 2024 • 7:38 PM EDT,

PermaLink

Melanie Senior

Nature Biotechnology

Review of Gilead Lung Cancer Study - Update on Phase 3 EVOKE-01 Study of Trodelvy® (sacituzumab govitecan-hziy; SG) vs. docetaxel in patients with metastatic or advanced NSCLC

23 Jan 2024 • 11:38 PM EST,

PermaLink

YouTube

Gilead Sciences' cancer drug Trodelvy® did not improve lung caner patients' survival in a phase 3 clinical trial. Stock share price plummeted

22 Jan 2024 • 9:55 AM EST,

PermaLink

gilead

A quick rant on healthcare company Humana

18 Jan 2024 • 2:44 PM EST,

PermaLink

YouTube

Carnage at Humana - company stock plunges as earning hit due to medical costs surge

18 Jan 2024 • 12:03 PM EST,

PermaLink

CNBC

Review of Pharma Company AbbVie: Part 2

17 Jan 2024 • 10:24 PM EST,

PermaLink

YouTube

Review of Pharma Company AbbVie: Part 1

17 Jan 2024 • 10:15 PM EST,

PermaLink

YouTube

Chinese gene-editing researcher Dr He Jianku, who reportedly created two gene-edited babies, starts lab in Beijing for gene therapy research, after serving 3-year jail sentence

28 Nov 2022 • 12:21 PM EST,

PermaLink

Staff Writer

Pandaily

China reports 3 cases of Covid deaths, the first time since May lockdown. With rising cases and outbreaks, the country may again tighten harsh Covid restrictions that were just eased. Markets fear further economic impact

21 Nov 2022 • 11:30 AM EST,

PermaLink

Phoebe Zhang

South China Morning Post

Merck to acquire cancer drug company Imago BioSciences for $1.35 billion to expand its portfolio to bone marrow diseases

21 Nov 2022 • 11:05 AM EST,

PermaLink

Raghav Mahobe

Reuters

FDA approves the first 'game-changing' treatment that delays onset of Type 1 diabetes. The drug, teplizumab, is developed New Jersey-based Provention Bio

19 Nov 2022 • 11:35 AM EST,

PermaLink

Adrianna Rodriguez

USA Today

Elizabeth Holmes, the Founder & former CEO of blood testing startup Theranos, sentenced to 11 years & three months in prison for fraud

19 Nov 2022 • 10:29 AM EST,

PermaLink

Condé Nast

Vogue

Eisai & Biogen's drug lecanemab for Alzheimer's disease shown to slow disease progress by 27% compared with a placebo, in a 1795-patient landmark clinical trial

28 Sep 2022 • 4:50 PM EDT,

PermaLink

Rebecca Robbins

New York Times

High profile gene editing startup Prime Medicine files for IPO

26 Sep 2022 • 4:45 PM EDT,

PermaLink

Ben Fidler

BioPharma Dive

When the Fed's fight inflation and stock market is struggling, biotech may offer a line of hope

21 Sep 2022 • 5:12 PM EDT,

PermaLink

Investor'S Business Daily

Investor's Business Daily

Catalent, one of the major pharma contract manufacturers, was cited by FDA for quality issues at its Covid-19 vaccine production site in Indiana

21 Sep 2022 • 5:27 PM EDT,

PermaLink

Tyler Patchen

Endpoints News

BrainStorm to seek FDA approval for its amyotrophic lateral sclerosis drug NurOwn. FDA rejected NurOwn last year. The company re-analyzed its phase III data, made corrections, and re-submitted to the Agency

15 Aug 2022 • 11:25 AM EDT,

PermaLink

Heather McKenzie

BioSpace

Monkeypox, whose transition once believed as self-limiting, forces researchers to re-learn how it spreads differently now, as cases ballooning rapidly around the globe (- Statnews)

15 Aug 2022 • 10:30 AM EDT,

PermaLink

Megan Molteni

STAT

Archived Story

Covid: as US cases decline and restrictions ease, Europe and Asia see cases surging with China re-instates lockdown in some areas and cities

Top News

Dexcom launches over-the-counter, prescription-free, continuous glucose monitor named Stelo. Recently Abbott also recevied FDA clearance of two similar devices

Eli Lilly launches a new form of weight loss drug Zepbound for as low as $399 a month

Nature Biotechnology article: Biotech financing: darkest before the dawn

Review of Gilead Lung Cancer Study - Update on Phase 3 EVOKE-01 Study of Trodelvy® (sacituzumab govitecan-hziy; SG) vs. docetaxel in patients with metastatic or advanced NSCLC

Gilead Sciences' cancer drug Trodelvy® did not improve lung caner patients' survival in a phase 3 clinical trial. Stock share price plummeted

A quick rant on healthcare company Humana

Carnage at Humana - company stock plunges as earning hit due to medical costs surge

Review of Pharma Company AbbVie: Part 2

Review of Pharma Company AbbVie: Part 1

Chinese gene-editing researcher Dr He Jianku, who reportedly created two gene-edited babies, starts lab in Beijing for gene therapy research, after serving 3-year jail sentence

China reports 3 cases of Covid deaths, the first time since May lockdown. With rising cases and outbreaks, the country may again tighten harsh Covid restrictions that were just eased. Markets fear further economic impact

Merck to acquire cancer drug company Imago BioSciences for $1.35 billion to expand its portfolio to bone marrow diseases

FDA approves the first 'game-changing' treatment that delays onset of Type 1 diabetes. The drug, teplizumab, is developed New Jersey-based Provention Bio

Elizabeth Holmes, the Founder & former CEO of blood testing startup Theranos, sentenced to 11 years & three months in prison for fraud

Eisai & Biogen's drug lecanemab for Alzheimer's disease shown to slow disease progress by 27% compared with a placebo, in a 1795-patient landmark clinical trial

High profile gene editing startup Prime Medicine files for IPO

When the Fed's fight inflation and stock market is struggling, biotech may offer a line of hope

Catalent, one of the major pharma contract manufacturers, was cited by FDA for quality issues at its Covid-19 vaccine production site in Indiana

BrainStorm to seek FDA approval for its amyotrophic lateral sclerosis drug NurOwn. FDA rejected NurOwn last year. The company re-analyzed its phase III data, made corrections, and re-submitted to the Agency

Monkeypox, whose transition once believed as self-limiting, forces researchers to re-learn how it spreads differently now, as cases ballooning rapidly around the globe (- Statnews)

Latest News

Dexcom launches first over-the-counter continuous glucose monitor.

Blood Sugar Tracking Heats Up: Dexcom's Over-the-Counter Sensor Now Available for Sale

Eli Lilly launches a new, cheaper form of weight loss drug Zepbound for as low as $399 a month

Biotech financing: darkest before the dawn

Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems

Gilead Lung Cancer Study Update #Gilead #lungcancer #clinicaltrial GILD

Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction?

Stock Price, Quote and News

Gilead Provides Update on Phase 3 EVOKE-01 Study

Humana warns higher medical costs may hit 2024 forecast